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Background: BPH is a common problem in aging men. It is characterized by lower urinary tract 
symptoms (LUTS) and some time may be associated with urinary incontinence and sexual 
dysfunction.  to investigate the safety and efficacy of trans-vesical prostatectomy donein a  
primary general hospital setting with limited facilities in Ethiopia. 
Methods:  This was a prospective cross sectional hospital based non-randomized study with a 
mean follow up of three months after operation. A total of 64 men were listed for Trans-vesical 
elective prostatectomy because of LUTS due to BPH. Co-morbidity, I-PSS, Indications, 
complications of anesthesia, weight of Prostate adenoma, duration of surgery, complications of 
surgery and patient satisfaction after surgery were studied. 
Results: the mean age of presentation was 63.8 +/- 9.9 years. Fifty four(84.4%) presented with 
one or more complication of Bladder out flow obstruction(BOO), of which acute urine 
retention(AUR) was the leading complication occurring in  52 (81.3%) followed by  recurrent 
UTI in 39 (60.9%) patients. The average duration of indwelling catheter before surgery was 
6.5 weeks, with a median of 4 weeks  and a range of 3days to 52 weeks. Spinal anesthesia was 
used in all except three patients and the average weight of prostate adenoma enucleated was 
73.6 +/- 32.2 grams.  An indwelling three way Foley catheter was required postoperatively for 
4.7 +/- 1.7 days. The mean operative time was 49.7 +/- 13.2 minutes and no death was 
encountered in this series. There was no early complication seen in 54 (84.3%) patients and 
blood transfusion was needed for only 3 (4.6%). Only one patient required re-admission for 
bladder neck stenosis. The international prostate symptom score (I-PSS) decrease from 32.8 
+/- 3.1 to 2.4 +/- 1.1 and patients were generally satisfied with the out come of surgery. 
 Conclusion: Trans-vesical prostatectomy is still safe and effective method of relieving                         
BOO due to BPH in the primary general hospital setting with comparable outcome to the 
current alternative treatment.  
      
Introduction 
 
 BPH is a common problem in aging men. It is characterized by lower urinary tract symptoms 
(LUTS) and some time may be associated with urinary incontinence and sexual dysfunction. 
Apart from the daily misery of these symptoms, if patients seek medical advice late, they 
could also suffer from complications like UTI, Pyelonephritis, stone formation, 
hydronephrosis and even renal failure1.The incidence of BPH rises dramatically with age. 
Autopsy studies have shown that the prevalence of histological benign prostate hyperplasia 
increase with age from approximately 8% for men aged 30-39 years to 40-50% of men aged 
more than 80 years.2 Population based studies have also shown that prostate volume increase 
with age.3,4 
 
In the last 25 years treatment options for BPH with concurrent BOO have greatly expanded to 
encompass medical and minimally invasive therapies. However these modalities are useful 
only for simple or moderate symptoms with small to medium sized prostate gland.5For most of 
patients living in developing nations like Ethiopia, who suffer not only from severe symptoms 
of BPH but also seek medical advice late after they develop complications like acute urinary 
retention, persistent /recurrent UTI, severe hemorrhage from the prostate, bladder calculi and / 
or renal insufficiency TURP or open prostatectomy is the treatment of choice6. Though TURP 
gained more popularity and is considered the gold standard, open prostatectomy still offers the 
advantage of lower re-treatment rate with complete removal of prostate adenoma and avoids 
the risk of dilution hyponatremia.7,8,9 In addition most of the hospitals in Ethiopia lack the 
necessary materials and trained urologist to do TURP. Therefore, under such circumstances, 
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open prostatectomy will continue to be the norm for surgical treatment of BPH. Among the 
different types of prostatectomy, the trans-vesical approach is the most commonly  performed 
one. How ever, the results of this procedure are not well studied in Ethiopian context. Review 
of literatures from a Med-line search using key word ‘transvesical prostatectomy’ shows few 
studies from Sub-Saharan countries and only one from Ethiopia.10,11,12Knowing the economic 
impact of BPH, patients suffering enormously from poor health and its treatment being 
substantial, it is absolutely essential to understand the impact of our treatment protocol. 
Besides, this study will add to the existing limited scientific papers available on the subject 
matter. Based on this objective, an attempt was made to assess the clinical indications, 
operative out comes, and complications of trans-vesical prostatectomy, done by a general 
surgeon at a rural primary general hospital setting with limited facilities.  
 
Patients and Methods  
 
A prospective analysis of 64 consecutive patients presenting with symptomatic BPH between 
Jan 1, 2005 and September 10, 2006 at Glenn C Olsen memorial primary general hospital was 
done. The hospital is a rural missionary hospital placed about 140 km south of Addis Ababa 
meant to serve the rural population. The operation room team is staffed with one general 
surgeon, one nurse anesthetist, one surgical nurse and two clinical nurses. All surgeries were 
done by a single general surgeon and patients were followed for 3 months post-operatively. 
Patients were initially evaluated by history, physical examination (including digital rectal 
examination) and I-PSS. The following investigations were done for all patients, CBC, blood 
group, BUN, creatinine, urine analysis, and abdominal ultrasound before surgery and during 
follow-up visit. Because of the lack of biplane endocavitory probe, prostate volume 
measurements were not done. Urodinamic studies were also not done due to lack of equipment. 
 
After obtaining informed consent, open trans- vesical prostatectomy was done using either 
spinal or general anesthesia. The bladder was approached through extra peritoneal supra-pubic 
mid line incision. Longitudinal cystostomy was performed and the bladder inspected. If there 
were foreign body fragments from long standing catheter or stones found, they were removed. If 
there were diverticulae, the larger ones were excised while smaller ones were obliterated. A 
Transverse incision using electrocautery posteriorly through  bladder neck mucosa between the 
trigon and prostate was made. Digital enuclation of the prostate adenoma was made beginning 
from the 10’ O’clock position by developing a plane between the adenoma and the prostatic 
false capsule.  
  
A haemostatic suture of either 2/0 or 3/0 chromic catgut was used routinely at 5 and 7 O’clock 
position. A three way Trans-urethral Foley catheter of number 20 or 22 FR was positioned 
inside the prostate fossa which was inflated to 20-40 ml according to the size of adenoma (This 
balloon was gradually deflated next day). The bladder was then closed with 1/0 or 2/0 chromic 
catgut running continuously in two layers. A Penrose drain was then placed in retroperitoneal 
area and brought out through a separate small incision laterally. Layered closure of abdominal 
wall incision was done. Post-operatively the catheter was connected to a sterile urine bag and 
intermittent irrigation done using normal saline. Once the urine was clear, catheter was removed 
at or after post operative day four. Hetrologous blood was given if clinically indicated. The 
adenoma was weighed and then sent for histological examination. If an incidental carcinoma 
was found the patient was excluded from the analysis. Patients were followed monthly for three 
months and during the final follow up visit they were interviewed for I-PSS, long term 
complications, sexual function, satisfaction with the out come of operation and its impact on the 
change of work ability and family life. After final data collection, data were entered in to a 
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Results 
 
 A total of 624 major operations were done during the study period of which transvesical 
prostatectomy done for BPH accounted for 64(10.5%). The mean age of presentation was 63.8 
+/- 9.9 years (range 46-90). The highest age specific prevalence was in the age group 60-65 
years(Fig 1).At presentation all patients were severely symptomatic with mean I-PSS of 32.8 +/- 
3.1 (Range 23-35). Out of the 64 patients, 54 (84.4%) of them presented with one or more 
complications of BOO. Of this 52/64 (81.3%) presented with AUR, 39(60.9%) with recurrent 
UTI, 21/64 (32.8%) with severe hemorrhage from prostate, 8/64(12.5%) with renal 
insufficiency(creatinine >1.5mg/dl) and 5/64 (7.8%) with bladder stones. All patients with high 
creatinine value were first treated by close continuous drainage before surgery. 
  
The average duration between initial catheterization for AUR and surgery was 6.5 weeks and 
median of 4 weeks (range 3 days-52 weeks) (Table 1). Delay in surgery was because patients 
were either referred from other health care units or were unable to meet the financial obligation 
for operation. Three patients came to us with suprapubic cystostomy, and one of them had supra-
pubic catheter for one year with out even being changed which finally formed a big intra-vesical 
stone around the tip of the catheter (Figure 3). As many as 45/64 (70.3%) patients had associated 
other co-morbidity. The most common co-morbidities identified before surgery were 
Hypertension 39/64 (60.9%), UTI 26/64 (32.7 %), PUD and other intestinal parasitosis 9/64 
(14.1%), pulmonary disease 6/64 (9.4%), CVS disease 5/64 (7.8%) and sepsis with leukocytosis 
4/64 (6.2 %). Transabdominal ultrasound examinations demonstrated mild/ moderate 
hydronephrosis in 14/64 (21.8%) patients and severe hydronephrosis in 1/64(1.6%). 
 
All patients received 1 gram of ceftriaxon 30 minutes before surgery and it was maintained with 
1gram every 12 hours for 5 more days after surgery. Most of the surgeries, 61/64(95.3%), were 
conducted with spinal anesthesia. General anesthesia was used for only 3/64(4.7%) patients.  
 
Table 1.  Descriptive Statistics in Age, Symptoms, Duration of Catheterization, Hospital Stay,  
                I-PSS, Weight of the Prostate and Time Of Surgery. 
 
 N Minimum Maximum Mean Std. 
Deviation 
  Age of the patient  
          ( years) 
64 46 90 63.86 9.901 
Duration of symptom  
          (months) 
64 2 36 13.88 9.833 
Duration of  
     catheterization 
           (weeks) 
64 0 52 6.55 9.616 
Duration of hospital 
stay 
           (days) 
64 4 14 6.94 1.717 
 IPSS (pre-operative) 64 23 35 32.08 3.189 
 IPSS (post-operative) 64 1 5 2.26 1.072 
 Weight of the 
prostate   
           (grams) 
64 25 190 73.66 32.263 
 Duration of surgery 
         (minutes) 
64 35 90 49.77 13.197 
Duration of catheter 
stayed post-op (days) 
64 4 8 4.77 .729 
Retro pubic drain 
stayed (hours) 
64 24 72 35.09 14.422 
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Table 2: Comparison in the out comes of Trans-vesical Prostatectomy Conservative 












Base line character     
   No. Patients         64     117        117     106 
   Mean Age +/- SD 63.8 +/- 9.9 66.4 +/- 7.9 67.4 +/- 8.1 67.2 +/- 7.8 
   Mean I-PSS 32.8 +/- 3.2 19.2 +/- 6.7 19.1+/- 6.6 18.8 +/- 6.5 
   Follow up time  3 month 7.5 month 7.5 month 7.5 month 
Primary outcome     
    Mean I-PSS   change from 
baseline 
 - 30.4 -12.3 -10.8  -1.3 
Secondary out come     
   No .of policy failure*   No  13 16 9 
  Average Hospital stay (days)  6.9  3.9 2.2 No 
  Catheter duration (Post 
operative in    days) 
4.7 2.4 11.8 No 
Major complications     
   Blood Transfusion ( 
Number) 
3 1 1 No 
   Septicemia 1 2 3 No 
   Prostatic capsule perforation No 2 1 No 
Death N No No No 
• Policy failure – Failure to complete treatment or need for further treatment before the 
initial follow up appointment. 
     †   Data collected from the present trans-vesical prostatectomy study 
     ‡   Date collected from a study done in United Kingdom by Donovan JL et al 15 
 
Figure 1. Interactive Graph showing the age specific prevalence of  
            64 patients operated for BPH  
50 60 70 80
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Fig-2 Age versus weight of adenoma of the prostate 
removed from 64 BPH patients
R Sq Linear = 0.104
 
Figure 3   Supra-pubic catheter which had stayed for one year with stones forming at  
           the tip of  catheter and Prostatic adenoma removed in a 65 years old patient 
  
 
                               
 
Transvesical prostatectomy was done for all patients and gross anatomic appearance showed 
5/64 (7.8%) isolated middle lobe, 39/64 (60.9%) isolated lateral lobe, 19/64 (29.7%) both 
middle and lateral lobe enlargement, and 1/64(1.6%) shows posterior commissural hyperplasia. 
The operative specimen weight was 73.6 +/- 32. 2 grams (range 25- 190). (Figure 2) Fifty four 
patients (84.3 %) had detrusor muscle hypertrophy and bladder mucosal trabecula. Eight patients 
(12.5%) had diverticulae of the bladder wall. The mean operative time was 49.7 +/- 13.2 minutes 
(range 35-90 minutes). All tissue was sent for routine pathological evaluation and incidental 
prostate carcinoma was found in one patient who was then excluded from final data analysis. 
There was no death and no early complications seen in 54/64(84.4%) patients. The only intra 
operative complications encountered were blood loss requiring transfusion, which was needed 
for only 3/64(4.6%) patients. No intra/post operative cardiovascular event like arrhythmias was 
seen. Five patients (7.8%) had clot retention with in 24 hours of operation and all except one 
responded to intermittent syringe irrigation. One patient was returned to the operating room for 
repeat cystostomy and was found to have the urethral catheter balloon displaced out from 
prostatic fossa.  
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Evacuation of the clot and placement of suprapubic cystostomy for continuous irrigation was 
done. Other early complications encountered were wound infection 5/64(7.8%), epididimo-
orchitis 2/64(3.2%), and pneumonia 1/64 (1.6%). No urine retention or leakage of urine via 
abdominal wound was encountered after removal of catheter.Average hospital stay was 6.94 +/- 
1.7 days (range 4-14 days) and three way transurethral Foley catheters remained in place for an 
average of 4.7 +/- 0.7 days (range 4-8 days). Postoperatively all patients were followed for 3 
months. Significant improvement in LUTS was observed as measured by post operative I-PSS. 
The mean I-PSS two weeks after surgery was 2.46 +/- 1.2 (range 1-5). And this value was 
significantly different from the pre-operative value (P < 0.001).  During the follow up time only 
one patient required re-admission for bladder neck stenosis and transvesical incision of bladder 
neck was done on him. Thirteen patients (20.3%) had temporary stress incontinence which 
ceased in the course of 12 weeks follow-up time. 
 
Analysis of sexual function showed that 53/64 (82.8%) had normal erection   before surgery and 
post-operatively 47/53 (88.6%) were able to maintain their penile erection. Of this 9/47 (19.1%) 
had developed retrograde ejaculation. It was found that all patients experienced marked 
improvement of symptoms after transvesical prostatectomy and were happy with the result of 
the operation. All of them have said their ability to work and their family life is much better than 
it was before. Finally, comparative presentations of data’s were made to show the safety and 
effectiveness of trans-vesical prostatectomy of the present analysis versus other data’s obtained 
from United Kingdom by Donovan JL. et al15 using other methods like contact laser therapy, the 




The American guide line group7,the UK British prostate group13,and the WHO sponsored 
International consensus committee (ICC) 14,  concur that in the diagnosis of BPH mandatory 
work-up which should be included are full medical history, digital rectal examination (DRE), 
urine analysis and serum creatinine. All this mandatory work-up for the diagnosis of BPH was 
used in all patients. There fore the results of this study can provide useful information for 
comparison with other treatment outcomes. The mean I-PSS at presentation found in this study 
(32.8+/-3.1) was significantly higher than similar studies done in the developed countries by 
Helfand B5 (18.5+/-1.3), Donvan JL15 (19.2+/-6.7) and Tubaro A19 (19.9+/-4.4). This could be 
due to the high incidence of BOO related complications seen and patients usually seek medical 
advise late in the course of illness. 
  
Compared to the UK national prostatectomy Audit16, complication related to BOO at 
presentation were found in less than 62%, versus 84.3 % of this study. Similar lower incidence 
(70%) was also documented in a hospital based study done by Nouri M17. This could be 
attributed to the large study population of the UK National prostatic Audit and Nouri M studies 
who reviewed 5361 and 1280 cases respectively. How ever hospital based studies with a similar 
number of cases showed comparable results. Helfand B found AUR (80.4%), bladder calculi 
(19.6%) and recurrent UTI (14.3%), Ahmed AA10 and Hill AG18 found 79% and 78% of AUR 
respectively before surgery. In a study done by Maier DE11 all had AUR at presentation.  The 
highest incidence of co-morbidity, especially hypertension seen here is because of the inclusion 
of mild hypertension and isolated systolic hypertension patients. Similar to other studies5, 11, 18, 19, 
spinal anesthesia is once again proved to be safe and effective way of anesthesia for trans-
vesical prostatectomy. The average weight of adenoma removed and the operation time is 
similar to studies done by Seretta V.20 and Hill AG. The prostate weight and operating time were 
much lower than those found by Helfand B ( 112.3 gram and 213.8 minutes respectively). The 
transfusion rate to replace blood loss during or after operation in this study (4.6%) was lower 
than reports from either developed nations or old African studies. McConnel7 (35%), and 
Helfand B (36%) from USA; Ahmed AA from Ethiopia and Jumbe24 from Zanzibar had similar 
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experience of 31% of cases requiring blood transfusion to replace blood loss following 
operation. Recent publications from Africa, like Hill AG (4.7%) of Kenya, Meier DE11 (4.6%) 
of Nigeria and Mohammed A. Labib21 (0%) of Zambia showed a similar or lower incidence. 
   
Using these old African studies as a historical control for comparison with current results could 
be difficult, because HIV has changed the out look on blood transfusion and decision are not 
based just on the surgical technique alone. How ever such discrepancy between the north and 
south nations could be due to the infrequent use of open prostatectomy in developed nations 
probably resulting in time the progressive loss of art22. History has shown that there has been a 
steady decline in mortality with this procedure.23 No patient died in this series while other 
studies showed a mortality of 3% and 0.9%10,18. According to Wasson6, the mortality for TURP 
ranges between 0.4 to 2.52 % for different age groups.   
 
The surgical complication rate found in this study is either similar or lower than those reports 
made in developed nations. For example Serrata in Italy reported severe bleeding in 11.6% with 
8.2 % transfusion rate, 8.6% sepsis rate and 3.6 % bladder neck stenosis requiring re-
intervention with in two years. Nouri17 found a high frequency of the late post operative 
complications. He found retrograde ejaculation in 100% after trans-vesical protatectomy and 
80% after TURP. The permanent incontinent rate was 1.18% after TURP and 1% after TVP.   
This low incidence of post operative complication in our study may be attributed to the 
relatively high incidence of younger patients in good preoperative condition, proper anesthesia 




The finding in this study shows that trans-vesical prostatectomy is still a useful technique in 
decreasing the prostatic burden of our society and can be carried out even with limited facilities. 
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